Announcements

A Form 4 filed on August 12, 2026, reports that Ana Silvia Corso Matte, a director of AXIA Energia S.A. (AXIA3), purchased 1,100 common shares on August 10, 2026, at a converted price of $9.86 per share.

Brian Flannery, VP and President of Stacy Adams at Weyco Group Inc (NASDAQ:WEYS), filed a Form 4 on August 12, 2026, reporting stock option exercises and a share disposition that occurred on August 11, 2026.

An amended statement of changes in beneficial ownership for UFP Technologies Inc director Joseph John Hassett was filed on August 12, 2026, correcting a share count error in a June 8, 2026 original filing.

Director Steven Bangert filed a Form 4 with the SEC on August 12, 2026, disclosing the sale of 1,250 shares of BOK Financial Corp common stock on August 11, 2026.

Daniel Karlin, Chief Medical Officer of Definium Therapeutics, Inc. (NASDAQ:DFTX), filed a Form 4 on August 12, 2026, reporting the acquisition of 100,000 common shares at $0.00 as the second tranche of a performance share unit award originally granted effective March 12, 2025.

Robert Barrow, Chief Executive Officer and Director of Definium Therapeutics, Inc. (NASDAQ:DFTX), filed a Form 4 on August 12, 2026, reporting the acquisition of 375,000 common shares through performance share units at a price of $0.00 per share.

A statement of changes in beneficial ownership filed on August 12, 2026 reports that Craig E. Boelte, a director of Paycom Software, Inc., disposed of 1,000 shares of common stock via a gift transaction on August 10, 2026.